Filings & corporate actions
2 results filed
CSVNext results · Q1 FY27
Due — expected by 14 Aug 2026
Estimate: filed 43–45 days after quarter end, last 4 times
Dividend
₹0.40 per share · last 19 Sept 2018
2026
Reaction to results · all yearsrose on day 0 in 1 of 74 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q4 FY26 | 17 Jul 2026 | +0.6% | +0.6% | -1.5% | 0.7× |
| Q3 FY26 | 13 Mar 2026 | -3.9% | -12.9% | +12.6% | 0.6× |
| Q2 FY26 | 14 Nov 2025 | — | — | — | — |
| Q1 FY26 | 14 Aug 2025 | — | — | — | — |
| Q4 FY25 | 31 May 2025 | — | — | — | — |
| Q3 FY25 | 15 Feb 2025 | — | — | — | — |
| Q2 FY25 | 17 Jan 2025 | — | — | — | — |
| Q1 FY25 | 16 Jan 2025 | — | — | — | — |
| Q4 FY24 | 15 Nov 2024 | — | — | — | — |
| Q3 FY24 | 15 Feb 2024 | — | — | — | — |
| Q2 FY24 | 15 Nov 2023 | — | — | — | — |
| Q1 FY24 | 14 Aug 2023 | — | — | — | — |
| Q4 FY23 | 31 May 2023 | — | — | — | — |
| Q3 FY23 | 13 Feb 2023 | — | — | — | — |
| Q2 FY23 | 15 Nov 2022 | — | — | — | — |
| Q1 FY23 | 12 Aug 2022 | — | — | — | — |
| Q4 FY22 | 6 Jun 2022 | — | — | — | — |
| Q3 FY22 | 14 Feb 2022 | — | — | — | — |
| Q2 FY22 | 13 Nov 2021 | — | — | — | — |
| Q1 FY22 | 13 Aug 2021 | — | — | — | — |
| Q4 FY21 | 29 Jun 2021 | — | — | — | — |
| Q3 FY21 | 13 Feb 2021 | — | — | — | — |
| Q2 FY21 | 14 Nov 2020 | — | — | — | — |
| Q1 FY21 | 29 Aug 2020 | — | — | — | — |
| Q4 FY20 | 25 Jul 2020 | — | — | — | — |
| Q3 FY20 | 15 Feb 2020 | — | — | — | — |
| Q2 FY20 | 15 Nov 2019 | — | — | — | — |
| Q1 FY20 | 9 Aug 2019 | — | — | — | — |
| Q4 FY19 | 1 Jun 2019 | — | — | — | — |
| Q3 FY19 | 1 Mar 2019 | — | — | — | — |
| Q2 FY19 | 22 Nov 2018 | — | — | — | — |
| Q1 FY19 | 31 Aug 2018 | — | — | — | — |
| Q4 FY18 | 25 Jun 2018 | — | — | — | — |
| Q3 FY18 | 23 Feb 2018 | — | — | — | — |
| Q2 FY18 | 22 Nov 2017 | — | — | — | — |
| Q1 FY17 | 4 Sept 2017 | — | — | — | — |
| Q4 FY17 | 4 Sept 2017 | — | — | — | — |
| Q1 FY18 | 4 Sept 2017 | — | — | — | — |
| Q3 FY17 | 17 Feb 2017 | — | — | — | — |
| Q2 FY17 | 14 Nov 2016 | — | — | — | — |
| Q4 FY16 | 1 Jun 2016 | — | — | — | — |
| Q3 FY16 | 19 Feb 2016 | — | — | — | — |
| Q2 FY16 | 13 Nov 2015 | — | — | — | — |
| Q4 FY15 | 3 Jun 2015 | — | — | — | — |
| Q3 FY15 | 19 Feb 2015 | — | — | — | — |
| Q2 FY15 | 26 Nov 2014 | — | — | — | — |
| Q1 FY15 | 20 Aug 2014 | — | — | — | — |
| Q4 FY14 | 6 Jun 2014 | — | — | — | — |
| Q3 FY14 | 19 Feb 2014 | — | — | — | — |
| Q2 FY14 | 22 Nov 2013 | — | — | — | — |
| Q1 FY14 | 17 Aug 2013 | — | — | — | — |
| Q4 FY13 | 24 Jun 2013 | — | — | — | — |
| Q3 FY13 | 22 Feb 2013 | — | — | — | — |
| Q2 FY13 | 15 Nov 2012 | — | — | — | — |
| Q1 FY13 | 5 Sept 2012 | — | — | — | — |
| Q4 FY12 | 1 Jun 2012 | — | — | — | — |
| Q3 FY12 | 14 Feb 2012 | — | — | — | — |
| Q2 FY12 | 16 Nov 2011 | — | — | — | — |
| Q1 FY12 | 17 Aug 2011 | — | — | — | — |
| Q4 FY11 | 31 May 2011 | — | — | — | — |
| Q3 FY11 | 31 Jan 2011 | — | — | — | — |
| Q2 FY11 | 25 Oct 2010 | — | — | — | — |
| Q1 FY11 | 16 Aug 2010 | — | — | — | — |
| Q4 FY10 | 31 May 2010 | — | — | — | — |
| Q3 FY10 | 29 Jan 2010 | — | — | — | — |
| Q2 FY10 | 28 Oct 2009 | — | — | — | — |
| Q1 FY10 | 1 Aug 2009 | — | — | — | — |
| Q3 FY09 | 21 Jan 2009 | — | — | — | — |
| Q2 FY09 | 4 Nov 2008 | — | — | — | — |
| Q1 FY09 | 31 Jul 2008 | — | — | — | — |
| Q3 FY08 | 24 Jan 2008 | — | — | — | — |
| Q2 FY08 | 5 Nov 2007 | — | — | — | — |
| Q1 FY08 | 27 Jul 2007 | — | — | — | — |
| Q4 FY07 | 30 Apr 2007 | — | — | — | — |
| Average | -1.7% | -6.2% | +5.6% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q4 FY26
CSVRevenue YoY-53.2%
Profit YoY—
Interest cost YoY—
Revenue QoQ-24.9%
Profit QoQ—
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Profit | — | — | — | — | — | — |
Key data
CSVOpen6.28
Day range6.28 – 6.28
52-week range—
From 52w high—
RSI (14)61.9
ATR (14)0.21
Volume27.9K
Avg volume (20D)29.3K
Rel volume0.95×
Volatility (1Y)55.7%
Turnover₹1.8L
SMA 50 / 2005.76 / —
Delivery percentage
Latest · 6 Oct 2026100.0%
20-day avg100.0%
1-year avg92.6%
Percentile (own history)100th
Range28.2–100.0%
Sessions197
Over the last 20 sessions VIVIMEDLAB settled 100.0% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 92.6%, so recent sessions are running 7.4 points higher than usual.
What delivery percentage measuresScan the whole market on delivery
Industry—
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +4.84% | +10.95% | -3.98% | +12.34% | +8.46% | — |
Valuation
CSVMarket cap₹10 Cr
P/E (TTM)—
EPS (TTM)-105.76
Shares outstanding1.66Cr
Listed—
Ownership
CSVPromoter7.57%
Promoter Δ QoQ-0.20 pp
Public92.43%
FII1.64%
DII0.00%
Pledged15.18%
Quarterly results · consolidated
CSV| Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 21.4 | 20.6 | 16.0 | 12.0 |
| YoY chg | — | — | — | -53.2% |
| Net profit (₹ Cr) | (5.5) | (7.3) | (16.6) | (146.0) |
| YoY chg | — | — | — | — |
| Net margin | -25.7% | -35.4% | -103.5% | -1217.0% |
| EPS | -0.64 | -0.85 | -0.85 | -17.22 |
Shareholding over time
CSVBy quarter
31 Mar 2026 · promoter 7.57% · public 92.43%2021-062026-03
- Promoter
- Public and others
- Promoter
- 7.57%
- Public
- 92.43%
- Promoter change
- -0.20 pp
- Filed
- 17 Apr 2026
- FII
- 1.64%
- DII
- 0.00%
- Promoter pledged
- 15.18%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25AR | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 35.4 | 33.6 | 41.5 | 38.6 | 29.4 | 24.8 | 36.5 | 25.6 | 21.4 | 20.6 | 16.0 | 12.0 | |
| Other income | 0.1 | 2.2 | 0.0 | 7.6 | 0.1 | 0.0 | 0.1 | 4.2 | 0.4 | 0.2 | 0.0 | 5.7 | |
| Total income | 35.5 | 35.8 | 41.5 | 46.2 | 29.4 | 24.8 | 36.6 | 29.8 | 21.8 | 20.8 | 16.0 | 17.7 | |
| Total expenses | 51.0 | 56.1 | 58.1 | 39.6 | 37.6 | 29.9 | 42.6 | 34.9 | 27.3 | 28.1 | 32.5 | 163.6 | |
| └ Finance costs | 10.7 | 11.9 | 13.2 | (33.3) | 0.3 | 0.4 | 0.5 | 1.7 | 0.6 | 1.7 | 1.0 | 0.9 | |
| └ Depreciation | 4.7 | 4.7 | 4.7 | 5.8 | 4.0 | 4.1 | 6.6 | 5.5 | 5.0 | 4.9 | 4.6 | 11.5 | |
| Profit before tax | (15.6) | (20.3) | (16.6) | 6.7 | (8.2) | (5.1) | (6.0) | (5.0) | (5.5) | (7.3) | (16.6) | (145.9) | |
| Tax expense | 0.0 | 0.0 | (0.6) | 1.4 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Net profit | (15.6) | (20.3) | (16.0) | 5.3 | (8.2) | (5.1) | (6.0) | (5.1) | (5.5) | (7.3) | (16.6) | (146.0) | |
| EPS | 1.88 | -2.45 | -1.24 | 0.64 | -0.99 | -0.60 | -0.72 | -0.67 | -0.66 | -0.88 | -0.88 | -17.74 | |
| Net margin | -44.06% | -60.34% | -38.71% | 13.63% | -27.88% | -20.75% | -16.37% | -20.06% | -25.68% | -35.43% | -103.53% | -1216.96% | |
| PBT margin | -44.06% | -60.34% | -40.04% | 17.23% | -27.88% | -20.75% | -16.37% | -19.61% | -25.68% | -35.43% | -103.53% | -1215.82% | |
| Tax rate | — | — | — | 20.91% | — | — | — | — | — | — | — | — |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 17 Jul 2026.
VIVIMEDLAB at a glance
- VIVIMEDLAB closed at ₹6.28 on 6 Oct 2026, +4.84% on the day.
- Delivery was 100.0% of traded quantity on 6 Oct 2026, the 100th percentile of its own 197 sessions with a reading (20-session average 100.0%, 1-year average 92.6%).
- Market capitalisation is ₹10 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-105.76).
- Q4 FY26 results (consolidated, filed 17 Jul 2026): revenue ₹12 crore (-53.2% year on year), net profit ₹-146 crore; the price moved +0.6% on the first session after.
- Promoters held 7.57% at 31 Mar 2026, down 0.20 percentage points on the previous filing, with 15.18% of promoter shares pledged.
- Q1 FY27 results are due; going by past filing dates they were expected by 14 Aug 2026.
About
CSVMacro sector—
Basic industry—
ISININE526G01021
SeriesBE
Listed—
History from18 Dec 2025
Sessions197
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
Other NSE equitys by turnover
CSV- GANGESSECUGanges Securities Limited115.82+2.62%
- MADHAVMadhav Marbles and Granites Limited33.93-0.44%
- GOENKAGOENKA0.82+1.23%
- PMLPaul Merchants Limited481.20-1.18%
- CREATIVEYECreative Eye Limited5.900.00%
- SAYAJIINDSAYAJIIND118.00-1.67%
- HBSLHB Stockholdings Limited57.91+3.74%
- SHIVAAGROSHIVAAGRO39.02+0.83%
- LKPSECLKPSEC14.30+0.28%
- HYBRIDFINHybrid Financial Services Limited17.56+0.75%
- NORBTEAEXPNorben Tea & Exports Limited64.21-2.10%
- ALFREDHEALFREDHE2,750.00+0.07%